Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma.

[1]  M. Fujimura,et al.  Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. , 1991, The Journal of allergy and clinical immunology.

[2]  T. Miyamoto,et al.  Effect of leukotriene antagonist on experimental and clinical bronchial asthma. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[3]  M. Fujimura,et al.  Attenuating effect of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to methacholine is specific to bronchial asthma. , 1990, Chest.

[4]  M. Fujimura,et al.  Effects of aerosol administration of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to acetylcholine in asthmatic subjects. , 1990, Chest.

[5]  A. Sheffer,et al.  A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. , 1989, The American review of respiratory disease.

[6]  K. Kato,et al.  A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. , 1989, Prostaglandins.

[7]  E. Israel,et al.  Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics. , 1989, The American review of respiratory disease.

[8]  J. Arm,et al.  The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. , 1988, The Journal of allergy and clinical immunology.

[9]  S. Holgate,et al.  Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects. , 1988, The Journal of pharmacology and experimental therapeutics.

[10]  K. Chung,et al.  Inflammatory mediators and asthma. , 1988, Pharmacological reviews.

[11]  N. Barnes,et al.  The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man. , 1987, The Journal of allergy and clinical immunology.

[12]  S P Hanley,et al.  The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma. , 1987, The Journal of allergy and clinical immunology.

[13]  E. R. Mcfadden,et al.  Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. , 1987, The American review of respiratory disease.

[14]  M. Fujimura,et al.  Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. , 1986, Thorax.

[15]  H. Bisgaard,et al.  Bronchial hyperreactivity to leucotriene D4 and histamine in exogenous asthma. , 1985, British medical journal.

[16]  M. Toda,et al.  New antagonists of leukotrienes: ONO-RS-411 and ONO-RS-347. , 1985, Advances in prostaglandin, thromboxane, and leukotriene research.

[17]  N. Barnes,et al.  Actions of inhaled leukotrienes and their interactions with other allergic mediators , 1984 .

[18]  N. Barnes,et al.  Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. , 1984, Thorax.

[19]  S. Hamano,et al.  Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. , 1983, European journal of pharmacology.

[20]  E. R. Mcfadden,et al.  Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.

[21]  C. Gill,et al.  The effect of synthetic leukotrienes on tracheal microvascular permeability. , 1983, Prostaglandins.

[22]  Bengt Samuelsson,et al.  Leukotrienes are potent constrictors of human bronchi , 1980, Nature.

[23]  J. Pepys.  The Mast Cell ‐its Role in Health and Disease , 1978 .